Skip to main content
. Author manuscript; available in PMC: 2006 May 30.
Published in final edited form as: J Am Coll Surg. 2004 May;198(5):685–696. doi: 10.1016/j.jamcollsurg.2004.01.025

Table 2.

Response of Patients with Metastatic Cancer Treated Using High-Dose Bolus Interleukin-2

n (%)
Diagnosis Total n Complete regression Partial regression Complete regression + partial regression
Melanoma 182 12 (7) 16 (9) 28 (15)
Renal cell cancer 227 21 (9) 22 (10) 43 (19)
Total 409 33 (8) 38 (9) 71 (17)

Patients accrued between September 1985 and November 1996.

Followup as of June 1, 2003 (median followup 11.9 y).